New hope to stop liver Cancer's return after surgery
NCT ID NCT07417397
Summary
This study is testing if adding a procedure called TACE after curative liver cancer surgery helps prevent the cancer from coming back. It will involve 442 patients who have had surgery but are at high risk of recurrence. Patients will be randomly assigned to either receive the TACE procedure or just have close monitoring to see which approach works better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, 530021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.